Atorvastatin favorably modulates a clinical hepatocellular carcinoma risk gene signature.
Kim MH, Kim MY, Salloum S, Qian T, Wong LP, Xu M, Lee Y, Shroff SG, Sadreyev RI, Corey KE, Baumert TF, Hoshida Y, Chung RT.
Kim MH, et al. Among authors: lee y.
Hepatol Commun. 2022 Sep;6(9):2581-2593. doi: 10.1002/hep4.1991. Epub 2022 Jun 16.
Hepatol Commun. 2022.
PMID: 35712812
Free PMC article.